Growth Hormone Disorders Completed Phase 3 Trials for Salicylic acid (DB00936)

Also known as: Growth Hormone Disorder

IndicationStatusPhase
DBCOND0036845 (Growth Hormone Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01502124Safety and Efficacy of Somatropin in Children With Growth Hormone DeficiencyTreatment